Discover how one patient with stage IIIC high-grade serous ovarian cancer achieved complete surgical resection via robotic techniques, completed carboplatin-paclitaxel therapy, and remains cancer-free on PARP maintenance 27 months later.
How One Patient Overcame Hidden Metastases and Now Thrives on Maintenance PARP Therapy Read More »
Discover how a 64-year-old patient with advanced, BRCA1/2 wild-type ovarian cancer overcame recurrence through surgical debulking, platinum re-challenge, and targeted rucaparib maintenance therapy.
Battling Advanced Ovarian Cancer: A 64-Year-Old’s Path to Targeted Maintenance Read More »
Discover how a BRCA1/2-negative Stage IIIC HGSC ovarian cancer patient overcame multiple brain metastases with surgery, targeted radiotherapy, and olaparib maintenance—remaining disease-free 63 months after diagnosis.
Defying Stage IIIC Ovarian Cancer: One Patient’s 63-Month Triumph Read More »
Discover how one 74-year-old patient with BRCA2-mutated Stage IVB ovarian cancer achieved 57 months of survival and avoided brain metastasis recurrence through gamma knife radiotherapy, targeted chemotherapy, and PARP inhibition.
Triumph Over Advanced HGSC: A 74-Year-Old’s 57-Month Survival Story Read More »
A second chance after a devastating stage 4 lung cancer diagnosis: Discover how Andrea R. regained hope through immunotherapy and the dedicated care of her medical team.
Finding Light in the Darkest Hour: A Busy Mom’s Stage IV Lung Cancer Miracle Read More »
A 53-year-old named Laurent was diagnosed with stage 4 lung cancer in June 2018. After immunotherapy and chemotherapy, he is now nearly in complete remission—proof that hope and advanced treatments can make all the difference.
Finding Hope and Strength: Laurent’s Triumph Over Stage IV Lung Cancer Read More »
Tejas P., MD, Assistant Professor, Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, and lung cancer survivor Lysa B. discuss how targeted therapy for ROS1-positive lung cancer offers hope and a better quality of life.
Rewriting the Rules: 12 Years of Targeted Therapy for Lysa’s Rare Lung Cancer Read More »
“There is much more hope.” These words from a 9+ year stage IV NSCLC survivor resonate deeply. Her journey, marked by multiple recurrences and triumphs, showcases the remarkable advancements in lung cancer treatment and the power of personalized medicine
Thriving 9½ Years with Recurrences – “Winning” with New Treatments Read More »
Man with stage IV lung cancer gets new lease of life after immunotherapy at Gurgaon hospital. Now nearly 80, he’s back on his feet, playing golf, and thriving years after his diagnosis.
Man with stage IV lung cancer gets new lease of life after immunotherapy Read More »
A Stage 4 lung cancer diagnosis nearly sidelined 33-year-old teacher and athlete, Adrian C. Thanks to precision therapies and supportive care, he reclaimed his active lifestyle—proving that advanced treatments can turn “bonus time” into a hopeful, fulfilling future.
A Remarkable Return to Teaching and Sports After Stage IV Lung Cancer Read More »
